General
=========================================================================

• Benign vulvar and vaginal tumor, first described in 1992 (Am J Surg Pathol 1992;16:373)
• No reported recurrences after excision

Epidemiology
=========================================================================

• Females of reproductive age (10% of patients are postmenopausal)
• Very rarely in males (scrotum, paratesticular tissue)

Sites
=========================================================================

• Vagina (10-15% of cases)
• Vulva (majority of cases)

Clinical features
=========================================================================

• Presents as slowly enlarging and painless mass
• May be mistaken for Bartholin's cyst or genital prolapse

Prognostic factors
=========================================================================

• Benign, rarely recurs when marginally excised
• Important to rule out angiomyxomatous or sarcomatous foci in rare cases

Case reports
=========================================================================

• 80 year old woman with angiomyofibroblastoma of the vagina and postmenopausal breast cancer treated with tamoxifen (Int J Gynecol Cancer 2006;16:581)
• 80 year old woman with angiomyofibroblastoma of the vulva with sarcomatous transformation (Am J Surg Pathol 1997;21:1104)

Treatment
=========================================================================

• Local excision

Gross description
=========================================================================

• Well circumscribed, soft, 0.5 to 12.0 cm, without necrosis
• May have pseudocapsule

Micro description
=========================================================================

• Circumscribed tumor with alternating hypercellular and hypocellular areas, spindle cells and plump stromal cells with eosinophilic cytoplasm that aggregate around small blood vessels
• May have binucleated or multinucleated cells
• Mast cells common
• Minimal stromal mucin, rare/no red blood cell extravasation, no atypia
• Rare/no mitotic figures

Micro images
=========================================================================

Zones of hypo and hypercellularity

Round to oval, plump spindle cells

Cytology description
=========================================================================

• Tumor cells with epithelioid or plasmacytoid features, may be binucleated or multinucleated

Positive stains
=========================================================================

• Vimentin, desmin (may be negative in postmenopausal patients), ER, PR

Negative stains
=========================================================================

• Actin (may have focal positivity), keratin, S100

Electron microscopy description
=========================================================================

• Well developed rough endoplasmic reticulum, Golgi apparatus, intermediate filaments, pinocytotic vesicles

Differential diagnosis
=========================================================================

• Angiomyxoma: not circumscribed, less cellular, fewer vessels; stromal mucin, RBC extravasation, infrequent plump stromal cells, no hyalinized vessels
• Cellular angiofibroma: hyalinized vessels, infrequent epithelioid or plasmacytoid nuclear features, more cellular, more fibrous stroma
• Fibroepithelial stromal polyp of vagina: no uninvolved Grenz zone; cells extend to dermal-epidermal junction (Int J Gynecol Pathol 2005;24:26)

Additional references
=========================================================================

• Fletcher: WHO Classification of Tumours of Soft Tissue and Bone (2013), Mod Pathol 1996;9:284

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).